Morinaga Milk says its postbiotic, marketed under the brand LAC-Shield, has been added into Thailand’s positive list of ingredients that could be used in general foods and beverages, opening new opportunities for functional foods development in the South...
Consumers in the Middle East are increasingly looking for protein-rich products to fulfil various needs, with claims ranging from sports performance to age-related muscle support.
Shanghai-headquartered TSI Group says that the approval of its muscle-support ingredient in South Korea will allow it to satisfy the needs of the local ageing population, and seize emerging opportunities in the sports nutrition category.
Supplement firms should not fall into the trap of thinking that novelty and attractive packaging will lead to instant success in China, with clinically proven ingredients, formulations, and delivery formats still the top three priorities, says TSI Group...
While dairy is the basis of protein nutrition, the use of plant-based and precision fermented protein is bound to increase in products such as infant formula, healthy ageing, and sports nutrition, says dairy multinational firm Friesland Campina.
South Korea-based nutra firm Yuhan Care says that while there are large untapped opportunities in Asia’s menopause market, the rate of growth is dependent on how effectively brands can change consumer perceptions about the topic.
China-based firm Jimi Biotech has successfully cultivated deer antler stem cells, which it looks to develop into its first commercialised product, while applications in dietary supplements and cosmetics are on the drawing board.
The unique health and nutritional needs of women throughout their life span, which remain a significant gap to fill, could be addressed with science-backed ingredients and targeted supplementation.
FrieslandCampina Ingredients is launching a "Step Up Nutrition" portfolio aimed at improving growth and development, immunity, cognitive development, mental health, and gut health in children aged three to twelve.
South East Asian countries, especially Vietnam, Thailand, Indonesia, and Malaysia present good opportunities for krill oil consumption growth in the next three to five years, says krill oil supplier Aker BioMarine.
dsm-firmenich is eyeing greater market share in Japan’s and South Korea’s functional food market by offering a new format known as "candy capsules" made by Taiwan firm Boncha Bio.
Singapore-headquartered TurtleTree is targeting sports nutrition success with its lactoferrin ingredient, with commercialisation in the US and Singapore expected this year and next year respectively.
The spike in demand for immune-related products has not dwindled after COVID-19, and is in fact showing signs of long-lasting potential, say several industry players.
Thai nutraceutical firm 3C Group aims to boost the growth of the local prebiotics sector, which it says is significantly less recognised than probiotics, through their application in functional products targeting children and people with gut issues.
The huge opportunities for innovating across women’s health for all life stages will be discussed by a leading industry expert at our forthcoming Growth Asia Summit in Singapore.
New Zealand researchers are optimistic that the flavouring, preserving, and texturing benefits provided by the native kanuka plant will lead to its effective commercialisation as a food ingredient.
Healthplex Expo 2023 / Natural & Nutraceutical Products China 2023
Adding certain probiotics to protein have shown to increase protease activity and in turn facilitate a higher rate of amino acid absorption, which could be a new point of market differentiation for the crowded protein supplement market, says South Korea’s...
India-based nutraceutical company Arjuna Natural is hoping to meet growing consumer demand for natural solutions to menstrual pain management with its turmeric-frankincense formulation.
More Chinese consumers have been taking krill oil supplementation in the past two to three years, with anti-ageing as one of the most common reasons, says CEO of krill oil supplier firm Aker BioMarine.
Taste remains paramount if consumers are going to be tempted to try and repeatedly purchase healthier and more functional products, claims ingredient giant Symrise.
High prices, “unscrupulous suppliers”, and inadequate identification methods have resulted in adulteration rates of saw palmetto extracts reaching 33% in Japan and as high as 75% in other Asian markets, says BGG World.
ADM says that consumers are increasingly looking for sports beverages that support both physical and emotional well-being, including focus, mood, energy, immunity, and digestive health.
While fish collagen peptide is most commonly associated with beauty-from-within nutraceuticals, firms could also increasingly explore its use in sports and active nutrition, according to PB Leiner.
New Zealand biotech firm NewFish is looking to accelerate the development and commercialisation of microalgae-based products through strategic partnerships, with the ambition of creating a “whole new category” in the future.
Swedish probiotic firm Probi is seeking growth in Thailand’s bone and immune health supplement market after its proprietary probiotic strain was added to the country’s positive list.
CJ Food & Nutrition Tech (CJ FNT) is pushing for greater presence in the global nutra market, as it diversifies its portfolio to target consumers with active lifestyles, athletes and esports players.
FrieslandCampina Ingredients said that consumer-led demand for prebiotics and the importance placed on gut health in Australia led the company to file for regulatory approval of its GOS prebiotic ingredient.
Florida-based ingredient firm Valensa International is expanding into South Korea’s joint health supplement market where it sees an opportunity for novel ingredients beyond glucosamine and chondroitin.
South Korea’s Ildong Bioscience has obtained invention patents for three of its probiotic strains for their vitamin production ability, specifically B-vitamins and vitamin C.
A prebiotic being used by pharma giant Bayer has “game-changing potential” due to its ability to negate common side effects, claims supplier NutriLeads, which is reporting growth in key APAC markets.
Sacco System is scaling up its Australian operations having recently launched a new research laboratory to service the growing microbial therapeutics market in APAC.
Australia’s Therapeutic Goods Administration (TGA) has approved for the first time the use of 3-fucosyllactose (3-FL) as a complementary medicine ingredient in listed medicines, such as dietary supplements.
The International Probiotics Association has announced it is expanding its scope to cover a broad range of ‘biotics’ in response to industry growth and market demand.
A Japanese company said it has managed to develop an olive leaf extract that could be incorporated into health supplements to promote stem cell reproduction.
Australia’s milk powder manufacturer ProviCo says that demand for specialised nutrition across different life stages has been growing and it is hoping to cater to such demand by utilising its expertise in milk protein fractionation.
A Shanghai-based nicotinamide mononucleotide (NMN) ingredient firm is hopeful of NMN’s application and business opportunities in the US, despite recent news of the USFDA retracting its status as a New Dietary Ingredient (NDI).
South Korean health supplement firm Yuhan Care, which is seen as a pioneer in the women’s health space domestically, is eyeing overseas expansion in China and South East Asia.
Pesticides contamination and traceability are among the top five concerns that nutraceutical brands have when procuring botanicals, according to Kerala-based Arishina Life Sciences, which has implemented a number of measures to mitigate these challenges.
Here we summed up the 10 most-read nutraceutical ingredient supplier news stories of the year, including Malaysia firm Nexus Wise’s tiger milk mushroom business, Singapore firm MD Pharmaceuticals developing a ‘faster-acting’ vitamin D product with DSM,...
DSM has reduced the production of its vitamin C in its factory at Jiangshan, China, as a string of factors, including economic uncertainties, inflation, and weakened demand has cause existing output at the current pricing to become unsustainable.
Kirin’s first human milk oligosaccharides (HMOs) production plant has commenced operation and the company anticipates that half of the market will be dominated by China in the future.
The taste and nutrition specialist aims to simplify formulation by including nutrient as well as legal requirements that cover 35 countries in an easy-to-use calculator. “This is something we have not experienced yet in the industry.”
